British Columbia Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.1M Sell
342,084
-101,142
-23% -$11.7M 0.24% 77
2025
Q4
$46.7M Buy
443,226
+81,689
+23% +$7.67M 0.25% 83
2025
Q3
$30.3M Sell
361,537
-34,908
-9% -$2.88M 0.17% 118
2025
Q2
$31.4M Sell
396,445
-87,325
-18% -$6.94M 0.18% 106
2025
Q1
$43.4M Sell
483,770
-1,638
-0.3% -$153K 0.27% 85
2024
Q4
$48.3M Buy
485,408
+62,801
+15% +$6.47M 0.29% 73
2024
Q3
$48M Sell
422,607
-62,496
-13% -$7.42M 0.29% 68
2024
Q2
$60.1M Buy
485,103
+181,520
+60% +$23.4M 0.36% 51
2024
Q1
$40.1M Buy
303,583
+11,485
+4% +$1.42M 0.28% 76
2023
Q4
$31.8M Buy
292,098
+61,191
+27% +$6.35M 0.26% 80
2023
Q3
$23.8M Buy
230,907
+1,614
+0.7% +$174K 0.23% 87
2023
Q2
$26.5M Buy
229,293
+2,581
+1% +$293K 0.25% 85
2023
Q1
$24.1M Buy
226,712
+1,903
+0.8% +$205K 0.25% 75
2022
Q4
$24.9M Sell
224,809
-25,781
-10% -$2.64M 0.27% 74
2022
Q3
$21.6M Sell
250,590
-43,041
-15% -$3.84M 0.24% 82
2022
Q2
$26.8M Sell
293,631
-96,565
-25% -$8.56M 0.25% 76
2022
Q1
$32M Sell
390,196
-54,859
-12% -$4.33M 0.2% 90
2021
Q4
$34.1M Sell
445,055
-23,182
-5% -$1.85M 0.19% 96
2021
Q3
$35.2M Sell
468,237
-148
-0% -$11.3K 0.21% 89
2021
Q2
$36.4M Buy
468,385
+33,008
+8% +$2.46M 0.22% 87
2021
Q1
$32M Sell
435,377
-13,172
-3% -$972K 0.23% 81
2020
Q4
$35M Sell
448,549
-10,927
-2% -$836K 0.25% 83
2020
Q3
$36.4M Buy
459,476
+33,251
+8% +$2.6M 0.3% 76
2020
Q2
$31.4M Buy
426,225
+134,363
+46% +$10.1M 0.31% 69
2020
Q1
$21.4M Sell
291,862
-341,334
-54% -$26.8M 0.36% 64
2019
Q4
$55M Sell
633,196
-219,147
-26% -$18M 0.41% 60
2019
Q3
$68.5M Sell
852,343
-129,371
-13% -$10.4M 0.66% 31
2019
Q2
$78.5M Buy
981,714
+89,739
+10% +$6.87M 0.69% 27
2019
Q1
$70.8M Sell
891,975
-293,523
-25% -$22M 0.63% 29
2018
Q4
$86.4M Buy
1,185,498
+153,880
+15% +$10.9M 0.77% 22
2018
Q3
$69.8M Sell
1,031,618
-323,128
-24% -$20.6M 0.74% 22
2018
Q2
$78.5M Sell
1,354,746
-272,558
-17% -$15.4M 0.69% 28
2018
Q1
$84.6M Sell
1,627,304
-126,141
-7% -$6.81M 0.64% 30
2017
Q4
$94.1M Sell
1,753,445
-125,364
-7% -$6.95M 0.66% 27
2017
Q3
$115M Buy
1,878,809
+151,359
+9% +$9.18M 0.89% 16
2017
Q2
$106M Sell
1,727,450
-184,504
-10% -$11.2M 0.84% 18
2017
Q1
$116M Buy
1,911,954
+149,789
+9% +$9.09M 0.92% 16
2016
Q4
$99M Buy
1,762,165
+190,749
+12% +$11.2M 0.87% 17
2016
Q3
$93.6M Sell
1,571,416
-223,329
-12% -$13.1M 0.94% 14
2016
Q2
$98.7M Buy
1,794,745
+7,376
+0.4% +$393K 0.87% 19
2016
Q1
$90.2M Buy
1,787,369
+29,473
+2% +$1.44M 0.85% 17
2015
Q4
$88.6M Sell
1,757,896
-32,715
-2% -$1.65M 0.85% 19
2015
Q3
$84.4M Sell
1,790,611
-19,450
-1% -$1.03M 0.86% 19
2015
Q2
$98.3M Sell
1,810,061
-79,211
-4% -$4.44M 0.93% 14
2015
Q1
$104M Sell
1,889,272
-402,734
-18% -$22.8M 0.94% 12
2014
Q4
$124M Sell
2,292,006
-37,460
-2% -$2.09M 1.03% 11
2014
Q3
$132M Sell
2,329,466
-91,866
-4% -$5.16M 1.11% 10
2014
Q2
$134M Sell
2,421,332
-29,270
-1% -$1.6M 1.08% 11
2014
Q1
$133M Sell
2,450,602
-185,021
-7% -$9.58M 1.12% 9
2013
Q4
$126M Buy
2,635,623
+79,936
+3% +$3.65M 0.99% 13
2013
Q3
$116M Sell
2,555,687
-358,992
-12% -$16.4M 0.98% 14
2013
Q2
$129M Buy
+2,914,679
New +$130M 1.06% 14

Other funds holding MRK

British Columbia Investment Management's MRK Position: Q1 2026 in Review

British Columbia Investment Management reduced its Merck (MRK) stake by 23% in Q1 2026, selling an estimated $11.7M and leaving 342,084 shares worth $41.1M. The position accounts for 0.24% of the portfolio, ranked #77.

British Columbia Investment Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $134M in Q2 2014. 3,782 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • British Columbia Investment Management held 342,084 shares of Merck worth $41.1M as of Q1 2026.
  • British Columbia Investment Management sold 101,142 Merck shares in Q1 2026, an estimated $11.7M.
  • Merck made up 0.24% of British Columbia Investment Management's portfolio in Q1 2026, its #77 holding.
  • British Columbia Investment Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • British Columbia Investment Management's Merck position peaked at $134M in Q2 2014.
  • 3,782 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.